Occasional Digest

Abivax closes down 9% following short report

Red Arrow Moving Down Over Graph Paper Background

MicroStockHub

Abivax (ABVX) closed Friday down ~9% following a short report from Scorpion Research, which attacked the clinical development of the company’s ulcerative colitis candidate obefazimod.

Scorpion revealed it has a short position in Abivax. The firm claims that the asset exhibits “

Source link

Exit mobile version